 This is a three-part study to assess the tolerability, safety, pharmacodynamics, and pharmacokinetics of ascending single doses including food interaction of ACT-453859 in healthy male subjects, of ascending multiple doses of ACT-453859 in healthy male and female subjects, and of multiple doses of setipiprant ACT-129968 in healthy male and female subjects. 